montgomery

Report: Cardeas Pharma raises $5M

Cardeas Pharma, a biotechnology company led by Seattle biotech entrepreneur Bruce Montgomery, has reeled in $5 million in venture financing from Novo Ventures, Avalon Ventures, WRF Capital and others, reports Xconomy. The round is expected to close with up to $7.5 million. Montgomery is a well regarded biotech leader, having previously sold Corus Pharma to Gilead Sciences… Read More

groovebipharma1

MicroRNA startup Groove Biopharma scores $6 million

It’s been a bit slow in Seattle venture capital circles in the past few months. But some of the region’s leading biotech investors are doing their part to pick up the pace as Groove Biopharma today is announcing $6 million in second round of financing. Backers of the company, housed at the biotech business incubator… Read More

mobisante-device-small

Ultrasound on the go? Smartphone-based imaging system released by Mobisante

Ultrasound systems can be bulky and expensive. But a Redmond company by the name of Mobisante is looking to transform the industry with a new technology that turns a smartphone into a miniature ultrasound device. Mobisante is expected to begin selling the $7,495 ultrasound attachment this month, with BusinessWeek noting that some top-end portable ultrasound… Read More